Talzenna Európai Unió - magyar - EMA (European Medicines Agency)

talzenna

pfizer europe ma eeig - talazoparib - mellnövekedés - daganatellenes szerek - talzenna az monoterápiában a felnőtt betegek kezelésére germline brca1/2 mutációk, akik her2-negatív, lokálisan előrehaladott vagy metasztatikus emlőrák. patients should have been previously treated with an anthracycline and/or a taxane in the (neo)adjuvant, locally advanced or metastatic setting unless patients were not suitable for these treatments. betegek hormon receptor (hr)-pozitív emlőrák kellett volna kezelni előtt endokrin alapú terápia, vagy tekinteni alkalmatlan az endokrin alapú terápia.

Brukinsa Európai Unió - magyar - EMA (European Medicines Agency)

brukinsa

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - daganatellenes szerek - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).